{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:52:41Z","timestamp":1790707961681,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.euf.2019.06.006","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T08:47:59Z","timestamp":1561106879000},"page":"329-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Urinary Biomarkers in Overactive Bladder: Revisiting the Evidence in 2019"],"prefix":"10.1016","volume":"5","author":[{"given":"Tiago","family":"Antunes-Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2019.06.006_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2019.06.006_bib0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-5347(05)00067-4","article-title":"Is the bladder a reliable witness for predicting detrusor overactivity?","volume":"175","author":"Hashim","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2019.06.006_bib0015","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1464-410X.2009.08361.x","article-title":"Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo controlled study","volume":"103","author":"Malone-Lee","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2019.06.006_bib0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11934-010-0130-8","article-title":"Urodynamics in the evaluation of overactive bladder","volume":"11","author":"Rovner","year":"2010","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.euf.2019.06.006_bib0025","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","article-title":"A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment","volume":"75","author":"Peyronnet","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2019.06.006_bib0030","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.neuro.29.051605.112929","article-title":"Neurotrophins: mediators and modulators of pain","volume":"29","author":"Pezet","year":"2006","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.euf.2019.06.006_bib0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrurol.2012.178","article-title":"Neurotrophins as regulators of urinary bladder function","volume":"9","author":"Ochodnicky","year":"2012","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euf.2019.06.006_bib0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/nau.22438","article-title":"Neurotrophins in bladder function: what do we know and where do we go from here?","volume":"33","author":"Cruz","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2019.06.006_bib0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ncpuro0408","article-title":"Mechanisms of disease: the role of nerve growth factor in the pathophysiology of bladder disorders","volume":"3","author":"Steers","year":"2006","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.euf.2019.06.006_bib0050","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/382431","article-title":"Biomarkers in overactive bladder: a new objective and noninvasive tool?","volume":"2011","author":"Antunes-Lopes","year":"2011","journal-title":"Adv Urol"},{"key":"10.1016\/j.euf.2019.06.006_bib0055","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/nau.21022","article-title":"Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target","volume":"30","author":"Ochodnicky","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2019.06.006_bib0060","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa0901510","article-title":"Tanezumab for the treatment of pain from osteoarthritis of the knee","volume":"363","author":"Lane","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2019.06.006_bib0065","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.juro.2010.12.088","article-title":"Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis","volume":"185","author":"Evans","year":"2011","journal-title":"J Urol"},{"issue":"4 Pt. 1","key":"10.1016\/j.euf.2019.06.006_bib0070","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.juro.2015.10.178","article-title":"Tanezumab reduces pain in women with interstitial cystitis\/bladder pain syndrome and patients with non-urological associated somatic syndromes","volume":"195","author":"Nickel","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2019.06.006_bib0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MOU.0000000000000064","article-title":"Biomarkers in lower urinary tract symptoms\/overactive bladder: a critical overview","volume":"24","author":"Antunes-Lopes","year":"2014","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euf.2019.06.006_bib0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.juro.2012.08.187","article-title":"Urinary neurotrophic factors in healthy individuals and overactive bladder patients","volume":"189","author":"Antunes-Lopes","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2019.06.006_bib0085","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0022-5347(05)00992-4","article-title":"Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder","volume":"175","author":"Kim","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2019.06.006_bib0090","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.juro.2008.01.146","article-title":"Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder","volume":"179","author":"Liu","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2019.06.006_bib0095","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/nau.22939","article-title":"The use of biomarkers in the diagnosis and treatment of overactive bladder: can we predict the patients who will be resistant to treatment?","volume":"36","author":"Alkis","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2019.06.006_bib0100","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00192-013-2104-0","article-title":"Urinary nerve growth factor: a biomarker of detrusor overactivity? A systematic review","volume":"24","author":"Rachaneni","year":"2013","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.euf.2019.06.006_bib0105","first-page":"e69","article-title":"Can urinary nerve growth factor be a biomarker for overactive bladder?","volume":"12","author":"Kuo","year":"2010","journal-title":"Rev Urol"},{"key":"10.1016\/j.euf.2019.06.006_bib0110","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1464-410X.2008.07757.x","article-title":"Urinary nerve growth factor levels could be a biomarker in the differential diagnosis of mixed urinary incontinence in women","volume":"102","author":"Liu","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2019.06.006_bib0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.urology.2016.08.048","article-title":"Urinary neurotrophin levels increase in women with stress urinary incontinence after a midurethral sling procedure","volume":"99","author":"Antunes-Lopes","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.euf.2019.06.006_bib0120","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1464-410X.2009.08380.x","article-title":"Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder","volume":"103","author":"Liu","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2019.06.006_bib0125","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/nau.21118","article-title":"Increased serum nerve growth factor levels in patient with overactive bladder syndrome refractory to antimuscarinic therapy","volume":"30","author":"Liu","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2019.06.006_bib0130","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.eururo.2008.04.037","article-title":"Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection","volume":"56","author":"Liu","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2019.06.006_bib0135","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/nau.23210","article-title":"Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis","volume":"36","author":"Sheng","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2019.06.006_bib0140","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/nau.23011","article-title":"Urinary neurotrophic peptides in postmenopausal women with and without overactive bladder","volume":"36","author":"Pennycuff","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2019.06.006_bib0145","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s11255-013-0621-x","article-title":"Association of inflammaging (inflammation\u2009+\u2009aging) with higher prevalence of OAB in elderly population","volume":"46","author":"Tyagi","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euf.2019.06.006_bib0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0090-4295(01)01124-4","article-title":"Estrogen and neuroinflammation","volume":"57","author":"Bjorling","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.euf.2019.06.006_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157449","article-title":"The BDNF Val66Met polymorphism influences reading ability and patterns of neural activation in children","volume":"11","author":"Jasinska","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2019.06.006_bib0160","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2174\/157015911798376253","article-title":"Neurotrophins in the lower urinary tract: becoming of age","volume":"9","author":"Frias","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.euf.2019.06.006_bib0165","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroscience.2010.01.015","article-title":"Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis","volume":"166","author":"Pinto","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.euf.2019.06.006_bib0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuroscience.2012.12.044","article-title":"Brain-derived neurotrophic factor, acting at the spinal cord level, participates in bladder hyperactivity and referred pain during chronic bladder inflammation","volume":"234","author":"Frias","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.euf.2019.06.006_bib0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11255-013-0540-x","article-title":"Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder","volume":"46","author":"Wang","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euf.2019.06.006_bib0180","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11884-017-0430-7","article-title":"Current concepts in urinary biomarkers for overactive bladder: what is the evidence?","volume":"12","author":"Pennycuff","year":"2017","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"10.1016\/j.euf.2019.06.006_bib0185","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1464-410X.2012.11672.x","article-title":"Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?","volume":"111","author":"Seth","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2019.06.006_bib0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11302-013-9395-y","article-title":"Purinergic signalling in the urinary tract in health and disease","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.euf.2019.06.006_bib0195","doi-asserted-by":"crossref","first-page":"F286","DOI":"10.1152\/ajprenal.00291.2013","article-title":"Purinergic and muscarinic modulation of ATP release from the urothelium and its paracrine actions","volume":"306","author":"Sui","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.euf.2019.06.006_bib0200","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1016\/S1569-9056(18)31277-6","article-title":"Detrusor underactivity (DU) caused by bladder outlet obstruction (BOO) is associated with an early impairment of the bladder sensory mechanism","volume":"17","author":"Vale","year":"2018","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.euf.2019.06.006_bib0205","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0022-5347(05)64632-0","article-title":"The contractile potency of adenosine triphosphate and ecto-adenosine triphosphatase activity in guinea pig detrusor and detrusor from patients with a stable, unstable or obstructed bladder","volume":"168","author":"Harvey","year":"2002","journal-title":"J Urol"},{"issue":"Suppl. 1","key":"10.1016\/j.euf.2019.06.006_bib0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11302-011-9271-6","article-title":"In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization","volume":"8","author":"Ford","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.euf.2019.06.006_bib0215","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/nau.22344","article-title":"Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls","volume":"32","author":"Cheng","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2019.06.006_bib0220","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/204604","article-title":"ATP during early bladder stretch is important for urgency in detrusor overactivity patients","volume":"2014","author":"Cheng","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.euf.2019.06.006_bib0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064696","article-title":"Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome","volume":"8","author":"Silva-Ramos","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2019.06.006_bib0230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2220\/biomedres.30.287","article-title":"Relationship between lower urinary tract symptoms and urinary ATP in patients with benign prostatic hyperplasia or overactive bladder","volume":"30","author":"Sugaya","year":"2009","journal-title":"Biomed Res"},{"issue":"3 Suppl. 1","key":"10.1016\/j.euf.2019.06.006_bib0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.urology.2003.11.003","article-title":"Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging","volume":"63","author":"Yoshida","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.euf.2019.06.006_bib0240","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/nau.22476","article-title":"Association between polymorphism of beta3-adrenoceptor gene and overactive bladder","volume":"33","author":"Honda","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2019.06.006_bib0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.02.052","article-title":"The relationship between the Trp 64 Arg polymorphism of the beta 3-adrenoceptor gene and idiopathic overactive bladder","volume":"205","author":"Ferreira","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.euf.2019.06.006_bib0250","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.4238\/2015.March.30.7","article-title":"Association between polymorphism of \u03b23-adrenoceptor gene and overactive bladder: a meta-analysis","volume":"14","author":"Qu","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.euf.2019.06.006_bib0255","doi-asserted-by":"crossref","unstructured":"Meekins AR, Murphy SK, Grenier C, et al. Role of \u03b2-3 adrenergic receptor polymorphism in overactive bladder. Neurourol Urodyn. [Epub ahead of print]. https:\/\/doi.org\/10.1002\/nau.24006.","DOI":"10.1002\/nau.24006"},{"key":"10.1016\/j.euf.2019.06.006_bib0260","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1476-5381.2008.00014.x","article-title":"Do gene polymorphisms alone or in combination affect the function of human beta3-adrenoceptors?","volume":"156","author":"Vrydag","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.euf.2019.06.006_bib0265","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89560","article-title":"Characterization of miRNA-regulated networks, hubs of signaling, and biomarkers in obstruction-induced bladder dysfunction","volume":"2","author":"Gheinani","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.euf.2019.06.006_bib0270","doi-asserted-by":"crossref","unstructured":"Antunes-Lopes T, Vale L, Coelho AM, et al. The role of urinary microbiota in lower urinary tract dysfunction: a systematic review. Eur Urol Focus. [Epub ahead of print]. https:\/\/doi.org\/10.1016\/j.euf.2018.09.011.","DOI":"10.1016\/j.euf.2018.09.011"},{"key":"10.1016\/j.euf.2019.06.006_bib0275","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01283-14","article-title":"The female urinary microbiome: a comparison of women with and without urgency urinary incontinence","volume":"5","author":"Pearce","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.euf.2019.06.006_bib0280","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00192-013-2325-2","article-title":"Urinary bacteria in adult women with urgency urinary incontinence","volume":"25","author":"Brubaker","year":"2014","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.euf.2019.06.006_bib0285","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00192-015-2847-x","article-title":"Incontinence medication response relates to the female urinary microbiota","volume":"27","author":"Thomas-White","year":"2016","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.euf.2019.06.006_bib0290","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fcimb.2016.00078","article-title":"Does the urinary microbiome play a role in urgency urinary incontinence and its severity?","volume":"6","author":"Karstens","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.euf.2019.06.006_bib0295","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/S1569-9056(19)30077-6","article-title":"Time to change microbiological approach to overactive bladder","volume":"18","author":"Perovic","year":"2019","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.euf.2019.06.006_bib0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.07.009","article-title":"The female urinary microbiome in urgency urinary incontinence","volume":"213","author":"Pearce","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.euf.2019.06.006_bib0305","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00192-018-3558-x","article-title":"A blinded observational cohort study of the microbiological ecology associated with pyuria and overactive bladder symptoms","volume":"29","author":"Gill","year":"2018","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.euf.2019.06.006_bib0310","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/1874285801408010148","article-title":"Pathogens in urine from a female patient with overactive bladder syndrome detected by culture-independent high throughput sequencing: a case report","volume":"8","author":"Siddiqui","year":"2014","journal-title":"Open Microbiol J"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456919301610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456919301610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:48:44Z","timestamp":1762498124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456919301610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2405456919301610"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2019.06.006","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary Biomarkers in Overactive Bladder: Revisiting the Evidence in 2019","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2019.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}